-
Mashup Score: 5How to Work with a Bad Listener - 2 year(s) ago
Here are some tips and tricks to improve your team communication and collaboration with a bad listener at work.
Source: 4PSA BlogCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 13
University of South Australia researchers are calling for exercise to be a mainstay approach for managing depression as a new study shows that physical activity is 1.5 times more effective than counseling or the leading medications.
Source: medicalxpress.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
We spoke to Dr Hemal Desai, Executive Director for Clinical Health, Aetna International. …
Source: bestpractice.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype - 3 year(s) ago
The Global Initiative for Asthma report recommends consideration of add-on biologics for patients with type 2 inflammation (blood eosinophils ≥150 cells/μL, fractional exhaled nitric oxide [Feno] ≥20 parts per billion or allergic asthma) whose asthma cannot be controlled by high-dose inhaled corticosteroids. In QUEST (NCT02414854), add-on dupilumab versus placebo was efficacious in patients with…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Men's sexual and reproductive health in cystic fibrosis in the era of highly effective modulator therapies-A qualitative study - PubMed - 3 year(s) ago
Men with CF acknowledge the need for comprehensive CF care that includes SRH and value early, stepwise, provider-initiated SRH conversations. Future work should seek a broader understanding of the impact of SRH on the mental health of men with CF as these concerns can have significant effects on the …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0State-Based Marketplaces 2.0 – Part 1: The Coming Expansion in Access, Affordability, and Value - 4 year(s) ago
By ROSEMARIE DAY and DAVID W. JOHNSON, The Affordable Care Act (ACA) survived its third challenge at the Supreme Court on June 18, 2021, by a 7-2 vote, signaling that Obamacare is here to stay. With a divided Congress and a Biden administration challenged by multiple urgencies, there is little hope for national legislation to…
Source: The Health Care BlogCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2
Dr. Marc Siegel on White House vaccination push: ‘I think you got to get there by convincing people it’s the right thing to do’
Source: Fox NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0The Cancer News Daily - 4 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes - 4 year(s) ago
In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their results have led to considering amendments in guidelines or actually already recommending corticosteroids in…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 0
Omalizumab, a monoclonal anti-IgE antibody, is an effective and safe add-on treatment option in patients with chronic spontaneous urticaria who respond poorly to 4-fold standard dose antihistamines.1 The recommended treatment dose of omalizumab is 300 mg every 4 weeks. In daily practice, interval shortening is used to intensify treatment in less responsive cases, whereas interval prolongation is…
Categories: Allergy-Immunology, Latest HeadlinesTweet
Effective #communication is crucial for #success in any workplace. For the process to be #effective, you need good speakers and good listeners. Let's discuss the situation in which you have to deal with a bad listener 👇 https://t.co/WgNyqE5CH9 From @4psa https://t.co/h8rHrzyqcZ